Literature DB >> 12955179

Synthetic and natural surfactant differentially modulate inflammation after meconium aspiration.

Anne Hilgendorff1, Daniel Rawer2, Martin Doerner2, Erol Tutdibi2, Michael Ebsen3, Reinhold Schmidt4, Andreas Guenther4, Ludwig Gortner2, Irwin Reiss2.   

Abstract

OBJECTIVE: Meconium aspiration syndrome remains a relevant cause of neonatal respiratory failure and is associated with severe pulmonary changes including surfactant inactivation and pronounced inflammatory changes. The present study investigated the effect of two different surfactant preparations-recombinant surfactant protein C surfactant (rSP-C Surf) and natural bovine surfactant-on pulmonary gas exchange and inflammatory response. DESIGN AND
SUBJECTS: Twenty-three newborn piglets were intubated, mechanically ventilated, received 5 ml/kg 20% sterile meconium for induction of lung injury, and were randomized thereafter for controls ( n=7), rSP-C Surf ( n=8), or natural surfactant ( n=8). Surfactants were given as an intratracheal bolus (75 mg/kg) and animals were further ventilated. MEASUREMENTS AND
RESULTS: Lung function variables, arterial blood gas samples and lung tissues were obtained. Histological evaluation was performed in right lung tissue using an established score. Cytokine mRNA expression (left lung tissue) was quantified using TaqMan real-time PCR (DeltaDeltaCT method, normalized to controls). In addition to significant improvement in gas exchange and lung function, histological evaluation showed significantly lower sum scores in the rSP-C Surf group than in controls). Cytokine mRNA expression of IL-1beta in whole lung tissue was significantly lower after administration of rSP-C Surf than in natural surfactant and controls whereas IL-10 mRNA expression was significantly induced in both surfactant groups.
CONCLUSIONS: Surfactant administration improved both gas exchange and pulmonary inflammatory cytokine transcription. Mechanisms underlying the differential inflammatory response in both surfactant preparations need to be further addressed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12955179     DOI: 10.1007/s00134-003-1984-8

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  39 in total

1.  Effect of meconium on the rate of in vitro subtype conversion of swine pulmonary surfactant.

Authors:  Ryota Kakinuma; Hiroshi Shimizu; Yunosuke Ogawa
Journal:  Eur J Pediatr       Date:  2002-01       Impact factor: 3.183

2.  Surfactant lavage for meconium aspiration: a word of caution.

Authors:  John Kattwinkel
Journal:  Pediatrics       Date:  2002-06       Impact factor: 7.124

3.  Human meconium has high phospholipase A2 activity and induces cellular injury and apoptosis in piglet lungs.

Authors:  R Holopainen; H Aho; J Laine; H Peuravuori; H Soukka; P Kääpä
Journal:  Pediatr Res       Date:  1999-11       Impact factor: 3.756

4.  Alteration of fatty acid profiles in different pulmonary surfactant phospholipids in acute respiratory distress syndrome and severe pneumonia.

Authors:  R Schmidt; U Meier; M Yabut-Perez; D Walmrath; F Grimminger; W Seeger; A Günther
Journal:  Am J Respir Crit Care Med       Date:  2001-01       Impact factor: 21.405

5.  A reagent for the non-destructive location of steroids and some other lipophilic materials on silica gel thin-layer chromatograms.

Authors:  R S Wright
Journal:  J Chromatogr       Date:  1971-07-08

6.  Injury responses to different surfactants in ventilated premature lamb lungs.

Authors:  Machiko Ikegami; Alan H Jobe
Journal:  Pediatr Res       Date:  2002-06       Impact factor: 3.756

7.  Cell death and lung cell histology in meconium aspirated newborn rabbit lung.

Authors:  A Zagariya; R Bhat; B Uhal; S Navale; M Freidine; D Vidyasagar
Journal:  Eur J Pediatr       Date:  2000-11       Impact factor: 3.183

8.  Platelet-activating factor in surfactant preparations.

Authors:  F R Moya; D R Hoffman; B Zhao; J M Johnston
Journal:  Lancet       Date:  1993-04-03       Impact factor: 79.321

9.  Surfactant replacement therapy for meconium aspiration syndrome.

Authors:  R D Findlay; H W Taeusch; F J Walther
Journal:  Pediatrics       Date:  1996-01       Impact factor: 7.124

10.  Saline lavage with substitution of bovine surfactant in term neonates with meconium aspiration syndrome (MAS) transferred for extracorporeal membrane oxygenation (ECMO): a pilot study.

Authors: 
Journal:  Crit Care       Date:  1999       Impact factor: 9.097

View more
  5 in total

Review 1.  Year in review in intensive care medicine-2003. Part 3: intensive care unit organization, scoring, quality of life, ethics, neonatal and pediatrics, and experimental.

Authors:  Edward Abraham; Peter Andrews; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Michael Pinsky; Peter Radermacher; Marco Ranieri; Christian Richard; Robert Tasker; Benoit Vallet
Journal:  Intensive Care Med       Date:  2004-06-26       Impact factor: 17.440

Review 2.  Surfactant therapy for meconium aspiration syndrome: current status.

Authors:  Peter A Dargaville; John F Mills
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Recombinant Human Superoxide Dismutase and N-Acetylcysteine Addition to Exogenous Surfactant in the Treatment of Meconium Aspiration Syndrome.

Authors:  Jana Kopincova; Maros Kolomaznik; Pavol Mikolka; Petra Kosutova; Juliana Topercerova; Katarina Matasova; Andrea Calkovska; Daniela Mokra
Journal:  Molecules       Date:  2019-03-05       Impact factor: 4.411

4.  An Unsettled Promise: The Newborn Piglet Model of Neonatal Acute Respiratory Distress Syndrome (NARDS). Physiologic Data and Systematic Review.

Authors:  Dietmar Spengler; Nele Rintz; Martin F Krause
Journal:  Front Physiol       Date:  2019-10-30       Impact factor: 4.566

5.  Surfactant replacement and open lung concept--comparison of two treatment strategies in an experimental model of neonatal ARDS.

Authors:  Anne Hilgendorff; Ece Aslan; Thomas Schaible; Ludwig Gortner; Thorsten Baehner; Michael Ebsen; Jochen Kreuder; Clemens Ruppert; Andreas Guenther; Irwin Reiss
Journal:  BMC Pulm Med       Date:  2008-07-14       Impact factor: 3.317

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.